Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cell Biol ; 195(2): 263-76, 2011 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-21987637

RESUMO

Mammalian Bcl-x(L) protein localizes to the outer mitochondrial membrane, where it inhibits apoptosis by binding Bax and inhibiting Bax-induced outer membrane permeabilization. Contrary to expectation, we found by electron microscopy and biochemical approaches that endogenous Bcl-x(L) also localized to inner mitochondrial cristae. Two-photon microscopy of cultured neurons revealed large fluctuations in inner mitochondrial membrane potential when Bcl-x(L) was genetically deleted or pharmacologically inhibited, indicating increased total ion flux into and out of mitochondria. Computational, biochemical, and genetic evidence indicated that Bcl-x(L) reduces futile ion flux across the inner mitochondrial membrane to prevent a wasteful drain on cellular resources, thereby preventing an energetic crisis during stress. Given that F(1)F(O)-ATP synthase directly affects mitochondrial membrane potential and having identified the mitochondrial ATP synthase ß subunit in a screen for Bcl-x(L)-binding partners, we tested and found that Bcl-x(L) failed to protect ß subunit-deficient yeast. Thus, by bolstering mitochondrial energetic capacity, Bcl-x(L) may contribute importantly to cell survival independently of other Bcl-2 family proteins.


Assuntos
Metabolismo Energético , Potencial da Membrana Mitocondrial/fisiologia , Membranas Mitocondriais/metabolismo , Proteína bcl-X/fisiologia , Animais , Sobrevivência Celular , Células Cultivadas , Proteínas Fúngicas , Camundongos , Camundongos Knockout , Microscopia Eletrônica , Mitocôndrias , Neurônios , Proteína bcl-X/deficiência
2.
Dev Cell ; 4(4): 575-85, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12689595

RESUMO

BAK is a pro-apoptotic BCL-2 family protein that localizes to mitochondria. Here we evaluate the function of BAK in several mouse models of neuronal injury including neuronotropic Sindbis virus infection, Parkinson's disease, ischemia/stroke, and seizure. BAK promotes or inhibits neuronal death depending on the specific death stimulus, neuron subtype, and stage of postnatal development. BAK protects neurons from excitotoxicity and virus infection in the hippocampus. As mice mature, BAK is converted from anti- to pro-death function in virus-infected spinal cord neurons. In addition to regulating cell death, BAK also protects mice from kainate-induced seizures, suggesting a possible role in regulating synaptic activity. BAK can alter neurotransmitter release in a direction consistent with its protective effects on neurons and mice. These findings suggest that BAK inhibits cell death by modifying neuronal excitability.


Assuntos
Apoptose/genética , Doenças do Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/metabolismo , Proteínas de Membrana/metabolismo , Neurônios/metabolismo , Transmissão Sináptica/genética , Fatores Etários , Animais , Animais Recém-Nascidos , Sistema Nervoso Central/fisiopatologia , Sistema Nervoso Central/virologia , Doenças do Sistema Nervoso Central/genética , Viroses do Sistema Nervoso Central/genética , Viroses do Sistema Nervoso Central/metabolismo , Modelos Animais de Doenças , Epilepsia/genética , Epilepsia/metabolismo , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Potenciais Pós-Sinápticos Excitadores/genética , Vetores Genéticos/genética , Hipocampo/metabolismo , Hipocampo/fisiopatologia , Hipocampo/virologia , Ácido Caínico , Masculino , Proteínas de Membrana/genética , Camundongos , Camundongos Knockout , Doenças Neurodegenerativas/genética , Doenças Neurodegenerativas/metabolismo , Neurônios/patologia , Neurônios/virologia , Neurotoxinas/genética , Neurotoxinas/metabolismo , Estrutura Terciária de Proteína/genética , Sindbis virus/genética , Acidente Vascular Cerebral/genética , Acidente Vascular Cerebral/metabolismo , Transmissão Sináptica/efeitos dos fármacos , Proteína Killer-Antagonista Homóloga a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...